Oriental Aromatics Q2 FY27 Share Price & Earnings Call Analysis

₹492.20-2.00% today
Market cap
₹1,655 Cr
P/E
159.62
ROE
0.50%
PEG
-3.56
Price to sales
1.49
Debt to equity
0.66
52W high / low
₹630 / ₹235
Sales growth (5Y)
7.78%
EBITDA margin
6.99%
Net profit margin
0.32%
Promoter holding
74.17%
Sales (last year)
₹1,112 Cr

Incorporated in 1973, Oriental Aromatics Ltd is a manufacturer of specialty-based aroma chemicals, camphor, and flavour and fragrance products[1]

Guidance scorecard · Q2 FY27 call

What Oriental Aromatics's management guided
and where it ranks in Chemicals & Petrochemicals

#62of 70 in
Chemicals & Petrochemicals

RevenueQ2 FY27 call

10–20%
  • The company targets a steady sales growth CAGR of 10% to 12% over the next 3-4 years.
  • Improvement in operational efficiencies and plant utilization, especially at Mahad, is expected to drive volume growth.
  • Strategic partnerships, like the one with Unilever, are anticipated to contribute positively to future revenue.
  • Continued strength in FMCG and personal care sectors is expected to support fragrance division growth.
  • Focus on sustainable and profitable growth across divisions, including expanding fragrance order pipelines domestically and internationally.
  • The company plans to maintain a 1/3rd:1/3rd:1/3rd sales ratio among its product segments, supporting balanced growth.

2 more points from Oriental Aromatics's call on revenue

Create a free account to keep reading this call

Full Q2 FY27 analysis

MarginsQ2 FY27 call

Flat

See what Oriental Aromatics said on margins — free account, 30 seconds.

Full Q2 FY27 analysis

CapexQ2 FY27 call

Planned
  • Currently, Oriental Aromatics Limited is in a consolidation phase with no substantial CAPEX in the last one and a half years.
  • The company is evaluating multiple options and products for future expansion.
  • There are plans to inform the investor community about upcoming CAPEX in the coming quarters.
  • The infrastructure at the Mahad facility has been designed to accommodate additional molecules and future phases of expansion.

2 more points from Oriental Aromatics's call on capex

Create a free account to keep reading this call

Full Q2 FY27 analysis

FundraisingQ2 FY27 call

See what Oriental Aromatics said on fundraising — free account, 30 seconds.

Full Q2 FY27 analysis

Order bookQ2 FY27 call

Rising
  • The company is seeing encouraging growth in its fragrance division with steady order flow.
  • There is ongoing progress in converting customer qualifications and commercial opportunities into actual sales, especially in the Mahad facility.
  • Conversations with existing and new customers indicate scaling up of allocations in RFQs.

2 more points from Oriental Aromatics's call on the order book

Create a free account to keep reading this call

Full Q2 FY27 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. 1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹1,878 Cr21.0
240%+Up 0–2%₹243 Cr3.1
340%+Flat₹7,887 Cr195.1
440%+Flat₹3,292 Cr4.3
540%+Flat₹2,311 Cr26.4
640%+Flat₹180 Cr11.8

Sign up free to see every company in the sector ranking and track Oriental Aromatics.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Oriental Aromatics

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Oriental Aromatics

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +74.17%74.17%74.17%74.17%74.17%74.17%74.17%74.17%74.17%74.17%74.17%74.17%
FIIs +0.10%0.10%0.10%0.05%0.08%0.07%0.02%0.03%0.03%0.00%0.02%0.00%
DIIs +0.39%0.39%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public +25.34%25.33%25.72%25.78%25.76%25.76%25.82%25.81%25.79%25.83%25.81%25.83%
No. of Shareholders26,54525,87525,71525,89827,21327,11826,25825,73425,03224,38223,72822,148

Financials of Oriental Aromatics

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +226.82197.41216.48215.76236.77222.57253.16225.52271.33251.56282.37259.81318.20
YoY Sales growth+2.75%-1.01%+10.82%+10.26%+4.39%+12.75%+16.94%+4.52%+14.60%+13.03%+11.54%+15.20%+17.27%
Expenses +215.81183.30195.60193.65208.15200.02233.89207.46254.09238.34262.91240.01292.93
Operating Profit11.0114.1120.8822.1128.6222.5519.2718.0617.2413.2219.4619.8025.27
OPM %4.85%7.15%9.65%10.25%12.09%10.13%7.61%8.01%6.35%5.26%6.89%7.62%7.94%
Other Income +2.812.161.741.692.100.090.240.273.002.064.271.000.50
Interest5.466.873.434.066.346.368.628.079.729.308.667.818.64
Depreciation4.944.965.084.895.166.407.237.707.817.827.747.727.80
Profit before tax3.424.4414.1114.8519.229.883.662.562.71-1.847.335.279.33
Tax %29.24%41.22%28.28%26.13%23.10%27.73%60.93%80.47%73.06%4.35%45.70%52.37%37.94%
Net Profit +2.422.6110.1210.9814.787.141.420.500.74-1.923.992.515.79
EPS in Rs0.720.783.013.264.392.120.420.150.22-0.571.190.751.72

Financials of Oriental Aromatics

Profit & Loss

Annual income statement trend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +4585067557607098738548429281,0311,112
Sales growth+11%+49%+1%-7%+23%-2%-1%+10%+11%+14%
Expenses +4004416396335537807997958359631,034
Operating Profit5765116127156935447946878
OPM %13%13%15%17%22%11%6%6%10%7%7%
Other Income +6-0-2714673108
Interest571312241320253634
Depreciation1415181917171920243131
Profit before tax444383103137762714481120
Tax %37%42%31%16%26%30%28%35%28%69%
Net Profit +282557861025320934310
EPS in Rs13.547.4316.9825.6130.2915.845.872.7010.200.983.09
Dividend Payout %3%7%6%10%8%9%9%18%5%51%

Financials of Oriental Aromatics

Balance Sheet

Capital structure and asset base

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital58171717171717171717
Reserves311329375447540588608616646648654
Borrowings +1051321835178140231206353403443
Other Liabilities +691039893110120130157129127186
Total Liabilities4905736736087458659869951,1451,1941,301
Fixed Assets +211212245236236265273270480460451
CWIP154012132553173558
Investments00000000000
Other Assets +264321428370496574661551660730841
Total Assets4905736736087458659869951,1451,1941,301

Financials of Oriental Aromatics

Cash Flows

Operating, investing and financing cash movement

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +16-2318117-1-22142-342
Cash from Investing Activity +-31-12-10-35-59-46-99-86-12
Cash from Financing Activity +1536-159165178-4812112
Net Cash Flow0012-2-99-5-03
Free Cash Flow-15-36171-18-60-6943-121-9
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit51%-0%162%36%23%-23%309%-20%11%

Financials of Oriental Aromatics

Ratios

Working capital efficiency and return ratios

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days80977773978181787489
Inventory Days141148149124211183233177238203
Days Payable41683943665255525044
Cash Conversion Cycle180177187154242213259203262247
Working Capital Days1179087109154151139999687
ROCE %11%19%21%24%12%5%4%8%4%

Guidance history

How Oriental Aromatics's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q2 FY27 call →10–20%FlatPlanned—Rising
Q1 FY27 call →10–20%FlatPlanned——
Q4 FY26 call →0–10%Up 0–2%Planned——
Q3 FY26 call →0–10%FlatPlanned—Rising

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

44out of 100

Momentum score · price trend

44 out of 100 — Steady

Over the past year its share price has moved roughly in the middle of the stocks we track.

PeriodShare price changeBetter than … of 1,928 stocks
Last 12 months+40.4%80%
Last 6 months+61.6%93%
Last 3 months+30.1%93%

The price is 51.8% below its all-time high of ₹1,021.35 (17 Sept 2021). Stocks more than 20% below their peak have their score halved, so 88 became 44.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,928 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Oriental Aromatics: 0.4 × 80 + 0.4 × 93 + 0.2 × 93 = 88, halved to 44 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 9 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Chemicals & Petrochemicals this season

  • Unilex Colour &C (Q2 FY27)

    685.02 lakhs (Consolidated) with a YoY increase of approximately 2.22% (Rs. Key results statement takeaways from Unilex Colour & Chemical Ltd's Q2 FY27 results

  • Andhra Sugars (Q2 FY27)

    3,276.52 lakhs (~5.5% increase) . Key results statement takeaways from Andhra Sugars Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Shanti Inorganics (Q2 FY27)

    54.02 crore (Rs. Key results statement takeaways from Shanti Inorganics Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Prolife Industries (Q2 FY27)

    Year-on-Year Change for PAT**: Specific YoY % change not provided; previous period PAT for the half year ended Sept 30, 2025 is not provided in the shared…